MedCAD Introduces New 3D-Printed AccuPlate® Product called AccuPlate® 3DTi™

3D Printing Allows Faster Turnaround and More Design Features

DALLAS, TX (December 9, 2024) —  MedCAD, creators of AccuPlate® patient-matched titanium implants, has announced that AccuPlate® reconstruction plates for the mandible and midface are now 3D printed. The 3D printed titanium plates allow for a shorter delivery window, as well as more geometries and features to address more surgical needs and complexities.

“MedCAD’s expansion of 3D titanium printing capabilities has enabled us to reduce delivery times dramatically for our high-demand implants while offering more design features requested by our customers,” said Nancy Hairston, CEO and president of MedCAD. “These improved turnaround times for each patient-specific plate can quickly provide surgeons with bespoke, creative reconstruction options within timeframes that were previously unavailable.”

The plates are available in thicknesses of 2.0 millimeters (mm), 2.4 mm, 2.6 mm and 2.8 mm. Highly requested features like inferior border hooks, as well as graft trays and precise allowances for off-the-shelf mesh between the plate and mandible, are all newly available options. Additionally, locking and non-locking threaded plate features or 3D printed mesh features combined with the plate are now available. The AccuPlate® 3DTi™ implants can be delivered in as few as five days after surgeon approval.

“The goal of MedCAD’s portfolio of product solutions is to provide surgeons with customizable options that are as anatomically unique as the patients they help treat,” says Hairston. “With MedCAD’s technology in the hands of a creative surgeon, the possibilities are virtually endless, and outcomes are unmatched.”

About MedCAD 

MedCAD is a Dallas-based, privately held medical technology company built on an innovative approach to the design and production of patient-matched medical devices. Harnessing precise imaging, surgical experience, and advanced design and manufacturing technologies, MedCAD creates personalized, patient-matched medical devices and surgical plans for cranial defects, oral surgery, CMF trauma and reconstructive surgical procedures. The approach is 100% patient-customized, with every device and every procedure planned and manufactured in-house in cooperation with a patient’s surgeon. By minimizing surgical complexity and procedure time, MedCAD technology enables superior patient outcomes throughout intervention, rehabilitation, and recovery.

Certain information set forth in this presentation contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.

These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.

Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.